PRESS RELEASEExperience Continues to Show CCM Therapy Addresses Clinical Need in Treating Heart Failure MARLTON, N.J., November 15, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure,...

PRESS RELEASE MARLTON, N.J., JUNE 14, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a commercial-stage medical device company focused on delivering our CCMTM therapy to people with heart failure, announced that the first implants in Europe for the newly launched...

PRESS RELEASE  Investigators Report Positive Findings From Feasibility Study of CCM in Heart FailureWith Preserved Ejection Fraction at the European Society of Cardiology Heart Failure 2022 Congress MADRID and MARLTON, N.J., May 23, 2022 (GLOBE NEWSWIRE) — Impulse...

PRESS RELEASE Financing To Support Commercial Acceleration of the Optimizer Smart Mini, Enrollment in the Landmark AIM HIGHer Clinical Trial, and Continued Development of a CCM-D Combination DeviceMARLTON, N.J., May 12, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a...

PRESS RELEASE Company Is Committed to Innovation for Patients Living With Heart Failure MARLTON, N.J., May 10, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is announcing...

PRESS RELEASE Smaller, Smarter, Long-lasting Device Gives Patients a Reason To Believe There Is a Tomorrow MARLTON, N.J., April 29, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure...

PRESS RELEASECCM Therapy Addresses an Unmet Clinical Need and Offers Hope to Millions With Heart Failure MARLTON, N.J., April 26, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure...

PRESS RELEASEImpulse Dynamics Is Now Among the First US-based Manufacturers of Active Implantable Devices To Receive Certification MARLTON, N.J., March 22, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a company dedicated to innovative treatments for chronic heart...

PRESS RELEASETrial Evaluates FDA-Designated BreakthroughTherapy for Patients Who Lack Treatment Options MARLTON, N.J., March 14, 2022 — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today...

NEWS Impulse Dynamics Announces Chief Financial Officer Transition Harriss Currie to Succeed Gerry Haines MARLTON, N.J., January 25, 2022 — Impulse Dynamics N.V., a company dedicated to improving the lives of people with heart failure, today announced the appointment...